Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2005

01-06-2005

The Role of Liver Resections for Noncolorectal, Nonneuroendocrine Metastases: Experience With 142 Observed Cases

Authors: Giorgio Ercolani, MD, Gian Luca Grazi, MD, Matteo Ravaioli, MD, Giovanni Ramacciato, MD, Matteo Cescon, MD, Giovanni Varotti, MD, Massimo Del Gaudio, MD, Gaetano Vetrone, MD, Antonio Daniele Pinna, MD

Published in: Annals of Surgical Oncology | Issue 6/2005

Login to get access

Abstract

Background

To evaluate the role of liver resection for noncolorectal, nonneuroendocrine metastases, indications and results were retrospectively reviewed in 142 observed patients.

Methods

A curative liver resection was performed in 83 cases (58.5%), and the remaining 59 patients received palliative treatments. The primary tumor site was gastrointestinal in 18, breast in 21, genitourinary in 15, leiomyosarcoma in 10, and other in 19. The mean number of metastases was 1.4. The mean diameter of the nodules was 5.7 cm. Liver metastases were synchronous in 11 (13.3%) cases and metachronous in the remaining 72 (86.7%).

Results

There was no operative mortality. Postoperative morbidity was 20.5%. The median postoperative stay was 9.5 days. The 3- and 5-year actuarial survival rate was 49.5% and 34.3% in resected cases, respectively, whereas there were almost no survivors 3 years after diagnosis in unresected cases (P < .05). The 3- and 5-year disease-free survival was 41.4% and 23.8%, respectively. Among the 83 resected cases, the 3- and 5-year actuarial survival was 17.3% and 8.6% for metastases from gastrointestinal tumors, 53.9% and 24.6% from breast cancer, 63.7% and 36.4% from leiomyosarcoma, 50.4% and 37.8% from genitourinary neoplasms, and 55.6% and 42.4% from other sites, respectively. Fifteen patients (18.1%) survived longer than 5 years.

Conclusions

Liver resection is an effective treatment for noncolorectal, nonneuroendocrine metastases; it allows satisfactory long-term survival with an acceptable operative risk in selected patients. Hepatic metastases from gastrointestinal carcinoma have the worst prognosis; those from genitourinary tumors show a better outcome. Patient selection is the key to achieving encouraging results.
Literature
1.
2.
Minagawa, M, Makuuchi, M, Torzilli, G,  et al. 2000Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Long term resultsAnn Surg21348799CrossRef
3.
Malafosse, R, Penna, C, Sa Cunha, A, Nordlinger, B 2001Surgical management of hepatic metastases from colorectal malignanciesAnn Oncol1288794CrossRefPubMed
4.
Lodge, JP, Ammori, BJ, Prasad, KR, Bellamy, MC 2000Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastasesAnn Surg2314719CrossRefPubMed
5.
Ercolani, G, Grazi, GL, Ravaioli, M,  et al. 2002Liver resection for multiple colorectal metastases. Influence of parenchymal involvement and total tumor volume, vs number or location, on long term survivalArch Surg137118792CrossRefPubMed
6.
Ihse, I, Persson, B, Tibblin, S 1995Neuroendocrine metastases of the liverWorld J Surg197682CrossRefPubMed
7.
Grazi, GL, Cescon, M, Pierangeli, F, Ercolani, G, Gardini, A, Cavallari, A 2000Highly aggressive policy of hepatic resections for neuroendocrine liver metastasesHepatogastroenterology474816PubMed
8.
Makowka, L, Tzakis, A, Mazzaferro, V,  et al. 1989Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreasSurg Gynecol Obstet16810711PubMed
9.
McEntee, GP, Nagorney, DM, Kvols, LK, Moertel, CG, Grant, CS 1990Cytoreductive hepatic surgery for neuroendocrine tumorsSurgery10810916PubMed
10.
Mazziotti, A, Cavallari, A 1997Techniques in Liver SurgeryGreenwich Medical MediaLondon
11.
Midorikawa, Y, Kubota, K, Takayama, T,  et al. 1999A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver diseaseSurgery12648491CrossRefPubMed
12.
Wolf, RF, Goodnight, JE, Krag, DE, Schneider, PD 1991Results of resection and proposed guidelines for patient selection in instances of noncolorectal hepatic metastasesSurg Gynecol Obstet17345460PubMed
13.
Harrison, LE, Brennan, MF, Newman, E,  et al. 1997Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patientsSurgery12162532CrossRefPubMed
14.
Berney, T, Mentha, G, Roth, AD, Morel, P 1998Results of surgical resection of liver metastases from noncolorectal primariesBr J Surg8514237CrossRefPubMed
15.
Lindell, G, Ohlsson, B, Saarela, A, Andersson, R, Tranberg, KG 1998Liver resection of noncolorectal secondariesJ Surg Oncol696670CrossRefPubMed
16.
Hemming, AW, Sielaff, TD, Gallinger, S,  et al. 2000Hepatic resection of noncolorectal, nonneuroendocrine metastasesLiver Transpl697101PubMed
17.
Couinaud, C 1989Surgical Anatomy of the Liver RevisitedC CouinaudParis
18.
Grazi, GL, Mazziotti, A, Jovine, E,  et al. 1997Total vascular exclusion of the liver during hepatic surgery. Selective use, extensive use, or abuse?Arch Surg13211049PubMed
19.
Schwartz, S 1995Hepatic resection for noncolorectal nonneuroendocrine metastasesWorld J Surg19725CrossRefPubMed
20.
Elias, D, Cavalcanti, A, Eggenspieler, P,  et al. 1998Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patientsJ Am Coll Surg18748793CrossRefPubMed
21.
Grazi, GL, Ercolani, G, Pierangeli, F,  et al. 2001Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added valueAnn Surg234718CrossRefPubMed
22.
Imamura, H, Matsuyama, Y, Shimada, R,  et al. 2001A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinomaAm J Gastroenterol96317884CrossRefPubMed
23.
Ochiai, T, Sasako, M, Mizuno, S,  et al. 1994Hepatic resection for metastatic tumors from gastric cancer: analysis of prognostic factorsBr J Surg8111758PubMed
24.
Okano, K, Maeba, T, Ishimura, K,  et al. 2002Hepatic resection for metastatic tumors from gastric cancerArch Surg2358691CrossRef
25.
Maehara, Y, Moriguchi, S, Kakeji, Y,  et al. 1991Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasesSurgery1108203PubMed
26.
Selzner, M, Morse, M, Vredenburgh, J, Meyers, W, Clanvien, P 2000Liver metastases from breast cancer: long term survival after curative resectionSurgery1273839CrossRefPubMed
27.
Raab, R, Nussbaum, KT, Behrend, M, Weimann, A 1998Liver metastases of breast cancer: results of liver resectionAnticancer Res1822313PubMed
28.
Yoshimoto, M, Tada, T, Saito, M, Takahashi, K, Uchida, Y, Kasumi, F 2000Surgical treatment of hepatic metastases from breast cancerBreast Cancer Res Treat5917784CrossRefPubMed
29.
Jaques, D, Coit, D, Casper, E, Brennan, M 1995Hepatic metastases from soft-tissue sarcomaAnn Surg2213927PubMed
30.
Chi, D, Fong, Y, Venkatraman, E, Barakat, R 1997Hepatic resection for metastatic gynecologic carcinomasGynecol Oncol664551CrossRefPubMed
31.
Goering, J, Mahvi, D, Niederhuber, J, Chicks, D, Rikkers, L 2002Cryoablation and liver resection for noncolorectal liver metastasesAm J Surg1833849CrossRefPubMed
32.
Bennet, BC, Selby, R, Bahnson, RR 1995Surgical resection for management of renal cancer with hepatic involvementJ Urol1549724CrossRefPubMed
Metadata
Title
The Role of Liver Resections for Noncolorectal, Nonneuroendocrine Metastases: Experience With 142 Observed Cases
Authors
Giorgio Ercolani, MD
Gian Luca Grazi, MD
Matteo Ravaioli, MD
Giovanni Ramacciato, MD
Matteo Cescon, MD
Giovanni Varotti, MD
Massimo Del Gaudio, MD
Gaetano Vetrone, MD
Antonio Daniele Pinna, MD
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2005.06.034

Other articles of this Issue 6/2005

Annals of Surgical Oncology 6/2005 Go to the issue

OriginalPaper

Sentinel Lymph Node Tumor Load: An Independent Predictor of Additional Lymph Node Involvement and Survival in Melanoma

OriginalPaper

Breast Conservation After Neoadjuvant Chemotherapy

Editorial

A Motion for Cautious Optimism in the Treatment of Patients With Ocular Melanoma: The Ayes Have It

Original

Correlation Between Concordance of Tracers, Order of Harvest, and Presence of Metastases in Sentinel Lymph Nodes With Breast Cancer

OriginalPaper

Treatment of Liver Metastases From Uveal Melanoma

OriginalPaper

Quality of Life and Functional Long-Term Outcome After Partial Pancreatoduodenectomy: Pancreatogastrostomy Versus Pancreatojejunostomy